top of page
Sirius Solutions Global website header with navigation menu: Home, Services, Specialties, Our Expertise, Resources, and Contact Us.
"Sirius Solutions Global Logo"

Dermatology Medical Necessity: How to Support Biopsies and Lesion Removal Claims

23 hours ago
6 min read
SIRIUS Solutions Global banner with two clinicians reviewing notes; headline about dermatology medical necessity, biopsies, lesion removal.

A dermatologist biopsies a changing mole, the pathology comes back, and the claim is still questioned. The procedure was appropriate, but the note says only “lesion, biopsy done.” Without the location, size, appearance, symptoms, change over time and the physician’s reasoning, the payer cannot see why the service was needed. Dermatology medical necessity rests on documentation that captures the lesion, the clinical concern, the assessment, the procedure performed and a diagnosis that matches. This guide explains how to support skin biopsy and lesion removal claims, where biopsy and removal differ and what drives denials. Payer policies vary, and clinical decisions remain with the treating provider.

Understanding medical necessity in dermatology

Medical necessity means the service was reasonable and needed for the patient’s condition under the payer’s coverage criteria. Payers separate it from cosmetic care, and the classification depends on the clinical picture and the policy, not the procedure name.

Diagnostic

Investigates or establishes a diagnosis, such as sampling a suspicious lesion.

Therapeutic

Treats an identified condition, such as removing a symptomatic or malignant lesion.

Cosmetic

Primarily improves appearance without a medical indication; usually not covered.

Coverage varies. Medicare local coverage policies titled “Removal of Benign Skin Lesions” differ by contractor (for example, LCD L34233 and LCD L33445). One states that removing benign lesions that pose no threat to health or function is cosmetic and not covered, and lists documented conditions that make removal medically necessary. Do not treat one LCD as a national rule, and check commercial payers separately.

Biopsy vs. lesion removal: important billing differences

Procedure

Primary purpose

Documentation focus

Billing consideration

Shave biopsy

Obtain tissue for diagnosis

Lesion characteristics, clinical suspicion

Tangential biopsy code when the intent is sampling

Punch biopsy

Obtain a tissue sample

Location, findings, procedure details

Punch biopsy code by lesion

Incisional biopsy

Remove part of a lesion

Reason for sampling, findings

Note must support what was done

Excisional biopsy

Remove a lesion for diagnosis

Lesion details, extent of removal

Distinguish from therapeutic excision

Benign lesion removal

Treat when medically indicated

Symptoms, irritation, bleeding, other findings

Diagnosis and payer policy requirements

Malignant excision

Treat a malignant lesion

Diagnosis, location, size, excision details

Malignant excision codes

Biopsy, destruction, shaving and excision are not interchangeable; code the technique and service actually documented. Some payers treat a biopsy done as part of a removal as inherent to it, and many require specific modifiers when one lesion is biopsied and another removed the same day. For example, a Novitas billing article says shave removal codes include tissue sent for pathology, and tangential biopsy codes apply when the sole intent is a pathologic diagnosis. Check each payer.

What should dermatologists document?

•      Location: anatomical site and laterality where applicable.

•      Size: measurements when relevant to code selection.

•      Appearance: color, shape, border, texture and surface.

•      Symptoms: pain, itching, bleeding, irritation or tenderness, when present.

•      Changes over time: reported or observed growth or color change.

•      Assessment and rationale: clinical concern, differential and why the procedure was appropriate.

•      Procedure and specimen: technique, extent, handling and pathology submission.

•      Follow-up: plan and pathology review.

☐  Lesion location documented                                         

☐  Relevant characteristics recorded

☐  Symptoms documented when present

☐  Clinical rationale clear

☐  Diagnosis reflects the assessment

☐  Procedure note describes technique

☐  Applicable measurements documented

☐  Pathology records maintained

☐  CPT code reviewed

☐  Payer requirements checked

Click the boxes in Word. Completed: ____ of 10. 0–4: documentation may need closer review. 5–7: several practices in place; review further. 8–10: covers many important elements; keep checking payer rules and coding. An educational checklist, not a guarantee of coverage, reimbursement or approval. Not every item applies to every procedure.

Important dermatology CPT code families

CPT code or range

Procedure (paraphrased)

Key documentation consideration

11102–11103

Tangential (shave) biopsy; first lesion and each additional

Intent to sample; lesion details

11104–11105

Punch biopsy; first and each additional

Site, findings, technique

11106–11107

Incisional biopsy; first and each additional

Why partial sampling

17110, 17111

Destruction of benign lesions such as warts, by count

Number and type of lesions; indication

11200, 11201

Skin tag removal by count

Symptoms if medically necessary

11300–11313

Shaving of epidermal or dermal lesions by site and size

Size, site, shave technique

11400–11446

Excision of benign lesions by site and diameter

Diameter with margins; why excision, not cosmetic

11600–11646

Excision of malignant lesions by site and diameter

Diagnosis, diameter with margins

Descriptions are paraphrased; confirm them in the current AMA CPT code set. A diagnosis alone does not establish medical necessity, and multiple lesions do not automatically mean multiple separately billable procedures.

ICD-10-CM diagnosis selection

Diagnosis codes must reflect the physician’s documented assessment. Relevant categories include D48.5 (neoplasm of uncertain behavior of skin), D22 (melanocytic nevi), D23 (other benign neoplasms of skin), C43 and C44 (malignant neoplasms of skin), L57.0 (actinic keratosis) and L82 (seborrheic keratosis). Verify each code in the current ICD-10-CM set. A suspected diagnosis should not be coded as confirmed malignancy. Pathology can add diagnostic detail, but follow ICD-10-CM outpatient guidelines and payer instructions on timing, and keep the original encounter documentation accurate. There is no universal diagnosis-to-CPT chart.

Common denial triggers

Denial risk

Why it happens

Documentation or RCM improvement

Insufficient clinical findings

Record does not explain why

Document lesion characteristics

Unclear diagnosis

Diagnosis does not reflect the assessment

Review diagnosis selection

Missing measurements

Information incomplete for code selection

Document applicable measurements

Cosmetic classification

No covered medical indication shown

Document the actual clinical rationale

Incorrect CPT selection

Code does not match technique

Check code against the procedure note

Missing supporting records

Notes or pathology unavailable

Keep complete records

Payer policy mismatch

Requirements differ by payer

Verify coverage policies

These are potential denial risks, not automatic denial rules.

Real-world billing scenarios (illustrative)

 

1. Changing pigmented lesion

2. Symptomatic benign lesion

3. Cosmetic removal

Documentation concern

Changes, exam findings, technique

Symptoms, site, procedure performed

Reason is appearance only

Billing consideration

Biopsy code that matches the technique

Removal code per technique; diagnosis supports symptoms

Usually noncovered; follow payer notice rules

Claim risk

Vague note, wrong biopsy code

“Irritated lesion” without detail

Misrepresenting cosmetic care as medical

Workflow fix

Templates for change and rationale

Prompt for symptoms

Advance notice process; accurate coding

How dermatology practices can improve claim accuracy

1

Use dermatology documentation templates

2

Educate clinical staff on key elements

3

Review CPT and ICD-10-CM selection

4

Check payer medical policies

5

Review claims before submission

6

Monitor denial trends

7

Reconcile pathology and procedure notes

8

Audit billing periodically

9

Track recurring revenue leakage

How Sirius Solutions Global supports dermatology billing and RCM

The Sirius Solutions Global website lists medical billing, medical coding, eligibility verification, denial management, prior authorization, credentialing, medical billing audit and A/R follow-up services, using AI-assisted checks with human verification. These can help a dermatology practice find process gaps, review claims before submission and track denials. Billing support cannot establish medical necessity; clinical documentation and decisions stay with the treating provider. Confirm dermatology scope with us. You focus on patient care — we’ll handle the rest.

Frequently asked questions

Q: What does medical necessity mean in dermatology billing?

That the service was reasonable and needed under the payer’s criteria, as shown in the record.

 

Q: What documentation supports a skin biopsy claim?

Location, appearance, size when relevant, symptoms or changes, clinical concern, technique and specimen handling.

 

Q: How is a skin biopsy different from lesion removal?

A biopsy samples tissue for diagnosis; removal treats or removes the lesion. Code the technique documented.

 

Q: What CPT codes are common for biopsies?

11102–11107 cover tangential, punch and incisional biopsies. Confirm in the current CPT set.

 

Q: Does every lesion removal qualify for coverage?

No. Cosmetic removal is generally not covered, and benign lesion criteria vary by payer.

 

Q: How should suspicious lesions be documented?

Record location, size, appearance, change over time, symptoms and your assessment.

 

Q: Why are biopsy claims denied?

Thin findings, unclear diagnosis, wrong code, missing records or payer-policy mismatch.

 

Q: Benign vs. malignant excision coding?

Separate code ranges (11400–11446 and 11600–11646) apply by site and diameter, supported by the diagnosis.

 

Q: Does pathology support medical necessity?

It adds diagnostic information but does not replace documentation of the original encounter.

 

Q: How can practices reduce denials?

Use templates, review codes and policies, check claims before submission and audit.

 

Q: Can a billing company review dermatology claims?

Yes, for coding, claim edits and denials. It cannot change clinical documentation.

 

Q: How does Sirius support dermatology billing?

Per its website, through billing, coding, eligibility, denial, A/R and audit services; confirm dermatology scope.

 

Sources and disclaimer

Medicare LCD L34233; LCD L33445; Novitas article A57113. Also AMA CPT and ICD-10-CM code files. For general information only; not legal, coding or clinical advice. CPT descriptions are paraphrased. Payer policies differ and change; verify before billing. Sirius Solutions Global does not guarantee coverage, reimbursement or approval. To request a correction, email Info@siriussolutionsglobal.com.


bottom of page